Flaxseed and Cardiovascular Risk

Nutrition Reviews

Volumn 62, Issue 1, 2004, Pages 18-27

  Bloedon, LeAnne T ^a   Szapary, Philippe O ^b  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cardiovascular disease; Cholesterol; Flaxseed; Lignans; linolenic acid

Indexed keywords

LIGNAN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOESTROGEN;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET; DIETARY FIBER; EPIDEMIOLOGICAL DATA; FOOD COMPOSITION; GLUCOSE ABSORPTION; HEART PROTECTION; HUMAN; LINSEED; NONHUMAN; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SECONDARY PREVENTION;

ALPHA-LINOLENIC ACID; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; DIETARY FIBER; FATTY ACIDS, OMEGA-3; FLAX; HEALTH FOOD; HUMANS; LIGNANS; RISK FACTORS;

EID: 1042301257     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2004.tb00002.x     Document Type: Review

References (75)

1. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, Texas: American Heart Association; 2002.
2. Hasler CM, Kundrat S, Wool D. Functional foods and cardiovascular disease. Curr Atheroscler Rep. 2000;2:467-475.
3. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive Summary of the third report of the National Cholesterol Education Progam (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
4. Kris-Etherton PM, Harris WS, Appel LJ, for the Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747-2757.
5. Judd A. Flax-some historical perspective. In: Cunnane SC, Thompson LUE, eds. Flaxseed in Human Nutrition. Toronto, CA: AOCS Press; 1995:1-10.
6. Blumenthal M. Herb sales down 3% in mass market retail stores - sales in natural food stores still growing, but at lower rate. HerbalGram. 2000;49:68.
7. Huget J. A bear market for supplements. Washington Post. 2001;May 15:HE06.
8. Bowen P. Evaluating the health claim of flaxseed and cancer prevention. Nutr Today. 2001;36:144-158.
9. Morris D. Essential nutrients and other functional compounds in flaxseed. Nutr Today. 2001;36:159-162.
10. Carter JF. Potential of flaxseed and flaxseed oil in baked goods and other products in human nutrition. Cereal Foods World. 1993;38:753-759.
11. Hunter JE. n-3 Fatty acids from vegetable oils. Am J Clin Nutr. 1990;51:809-814.
12. Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL. Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr Cancer. 2001;39:58-65.
13. Meagher LP, Beecher GR. Assessment of data on the lignan content of foods. J Food Comp Anal. 2000;13:935-947.
14. Meagher LP, Beecher GR, Flanagan VP, Li BW. Isolation and characterization of the lignans, isolariciresinol and pinoresinol, in flaxseed meal. J Agric Food Chem. 1999;47:3173-3180.
15. Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL. Flaxseed influences urinary lignan excretion in a dose-dependent manner in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000;9:1113-1118.
16. Kritchevsky D. Fiber effects of hyperlipidemia. In: Cunnane SC, Thompson LUE, eds. Flaxseed in Human Nutrition. Toronto, CA: 1995;174-186.
17. Wolever T. Flaxseed and glucose metabolism. In: Cunnane S, Thompson LU, eds. Flaxseed in Human Nutrition. Champaign, IL: AOCS Press; 1995:157-164.
18. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation. 1999;99:1355-1362.
19. Sanghvi A, Divven W, Seltman H. Inhibition of rat liver cholesterol 7-alpha hydroxylase and acetyl CoA:cholesterol aceyl transferase activities by entrodiol and enterolactone. In: Kritchevsky D, ed. Proceedings of the Symposium on Drugs Affecting Lipid Metabolism. New York: Plenum Press; 1984: 311-322.
20. Kitts DD, Yuan Y, Wijewickreme AN, Thompson LU. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem. 1999;202:91-100.
21. Hall AV, Parbtani A, Clark WF, et al. Abrogation of MRL/Ipr lupus nephritis by dietary flaxseed. Am J Kidney Dis. 1993;22:326-332.
22. Lanzmann-Petithory D, Pueyo S, Renaud S. Primary prevention of cardiovascular diseases by alphalinolenic acid. Am J Clin Nutr. 2002;76:1456-1457.
23. Kinsella JE, Lokesh B, Stone RA. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am J Clin Nutr. 1990;52:1-28.
24. Calder PC, Bevan SJ, Newsholme EA. The inhibition of T-lymphocyte proliferation by FA is in an eicosanoid-independent mechanism. Immunology. 1992;75:108-115.
25. Wallace FA, Miles EA, Calder PC. Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. Br J Nutr. 2003;89:679-689.
26. Cunnane SC, Ganguli S, Menard C, et al. High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr. 1993;69:443-453.
27. Finnegan YE, Minihane AM, Leigh-Firbank EC, et al. Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr. 2003;77:783-795.
28. Ratnayake WMN, Behrens W, Fischer P Chemical and nutritional studies of flaxseed (variety Linott) in rats. J Nutr Biochem. 1992;3:232-240.
29. Prasad K, Mantha S, V, Muir AD, Westcott ND. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis. 1998;136:367-375.
30. Prasad K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis. 1997;132:69-76.
31. MacDonald-Wicks LK, Garg ML. Modulation of carbon tetrachloride-induced oxidative stress by dietary fat in rats (open star). J Nutr Biochem. 2002; 13:87-95.
32. Rupp H, Turcani M, Ohkubo T, Maisch B, Brilla CG. Dietary linolenic acid-mediated increase in vascular prostacyclin formation. Mol Cell Biochem. 1996; 162:59-64.
33. Cherian G, Ahn DU, Sim JS. Blood and aorta lipid status and platelet function in swine modified by dietary alpha-linolenic acid-rich flax seed. J Agric Food Chem. 1996;44:2330-2335.
34. Prasad K, Mantha SV, Muir AD, Westcott ND. Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism. Mol Cell Biochem. 2000;206:141-149.
35. Prasad K. Secoisolariciresinol diglucoside from flaxseed delays the development of type 2 diabetes in Zucker rat. J Lab Clin Med. 2001;138:32-39.
36. Anderson JW, Hanna TJ, Peng X, Kryscio RJ. Whole grain foods and heart disease risk. J Am Coll Nutr. 2000;19:291 S-299S.
37. Hu FB, Stampfer MJ, Manson JE, et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr. 1999;69:890-897.
38. Djousse L, Pankow JS, Eckfeldt JH, et al. Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Clin Nutr. 2001; 74:612-619.
39. Baylin A, Kabagambe EK, Ascherio A, Spiegelman D, Campos H. Adipose tissue alpha-linolenic acid and nonfatal acute myocardial infarction in Costa Rica. Circulation. 2003;107:1586-1591.
40. Oomen CM, Ocke MC, Feskens EJ, Kok FJ, Kromhout D. α-Linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study. Am J Clin Nutr. 2001;74:457-463.
41. Vanharanta M, Voutilainen S, Lakka TA, van der LM, Adlercreutz H, Salonen JT. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study. Lancet. 1999;354:2112-2115.
42. Vanharanta M, Voutilainen S, Rissanen TH, Adlercreutz H, Salonen JT. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med. 2003;163:1099-1104.
43. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994; 343:1454-1459.
44. Singh RB, Dubnov G, Niaz MA, et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet. 2002;360:1455-1461.
45. Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, Moshiri M. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival - 4. Cardiovasc Drugs Ther. 1997;11:485-491.
46. Bierenbaum ML, Reichstein R, Watkins TR. Reducing atherogenic risk in hyperlipemic humans with flax seed supplementation: a preliminary report. J Am Coll Nutr. 1993;12:501-504.
47. Clark WF, Parbtani A, Huff MW, et al. Flaxseed: a potential treatment for lupus nephritis. Kidney Int. 1995;48:475-480.
48. Jenkins DJ, Kendall CW, Vidgen E, et al. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am J Clin Nutr. 1999;69:395-402.
49. Arjmandi BH, Khan DA, Juma S, et al. Whole flaxseed consumption lowers serum LDL-cholesterol and lipoprotein(a) concentrations in postmenopausal women. Nutr Res. 1998;18:1203-1214.
50. Lucas EA, Wild RD, Hammond LJ, et al. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab. 2002;87:1527-1532.
51. Cunnane SC, Hamadeh MJ, Liede AC, Thompson LU, Wolever TM, Jenkins DJ. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr. 1995;61:62-68.
52. Clark WF, Kortas C, Heidenheim AP, Garland J, Spanner E, Parbtani A. Flaxseed in lupus nephritis: a two-year nonplacebo-controlled crossover study. J Am Coll Nutr. 2001;20:143-148.
53. Lemay A, Dodin S, Kadri N, Jacques H, Forest JC. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol. 2002;100:495-504.
54. Harris WS. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S-1654S.
55. Kuroda T, Kondo K, Iwasaki T, Ohtani A, Takashima K. Synthesis and hypolipidemic activity of diesters of arylnaphthalene lignan and their heteroaromatic analogs. Chem Pharm Bull (Tokyo). 1997;45:678-684.
56. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21:495-505.
57. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr. 1996;63:116-122.
58. Thies F, Miles EA, Nebe-von-Caron G, et al. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids. 2001;36:1183-1193.
59. Hu FB, Manson JE, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr. 2001;20:5-19.
60. Allman MA, Pena MM, Pang D. Supplementation with flaxseed oil versus sunflowerseed oil in healthy young men consuming a low fat diet: effects on platelet composition and function. Eur J Clin Nutr. 1995;49:169-178.
61. Freese R, Mutanen M, Valsta LM, Salminen I. Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/alpha-linolenic acid ratio on platelet aggregation. Thromb Haemost. 1994;71:73-77.
62. Li D, Sinclair A, Wilson A, et al. Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men. Am J Clin Nutr. 1999;69:872-882.
63. Nestel PJ, Pomeroy SE, Sasahara T, et al. Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol. 1997;6:1163-1170.
64. Meagher EA, FitzGerald GA. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med. 2000;28:1745-1750.
65. Vanharanta M, Voutilainen S, Nurmi T, et al. Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis. 2002;160:465-469.
66. Bemelmans WJ, Muskiet FA, Feskens EJ, et al. Associations of alpha-linolenic acid and linoleic acid with risk factors for coronary heart disease. Eur J Clin Nutr. 2000;54:865-871.
67. Berry EM, Hirsch J. Does dietary linolenic acid influence blood pressure? Am J Clin Nutr. 1986;44:336-340.
68. Singer P, Naumann E, Hoffmann P, et al. Attenuation of high blood pressure by primrose oil, linseed oil and sunflowerseed oil in spontaneously hypertensive rats. Biomed Biochim Acta. 1984;43:S243-S246.
69. Kestin M, Clifton P, Belling GB, Nestel PJ. n-3 Fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants. Am J Clin Nutr. 1990;51:1028-1034.
70. McManus RM, Jumpson J, Finegood DT, Clandinin MT, Ryan EA. A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care. 1996;19:463-467.
71. Gall H. Food-dependent exercise-induced anaphylaxis to flaxseed. Allergy Int. 2000;49:219-221.
72. Phipps WR, Martini MC, Lampe JW, Slavin JL, Kurzer MS. Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol Metab. 1993;77:1215-1219.
73. Demark-Wahnefried W, Price DT, Polascik TJ, et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001;58:47-52.
74. Tou JC, Chen J, Thompson LU. Flaxseed and its lignan precursor, secoisolariciresinol diglycoside, affect pregnancy outcome and reproductive development in rats. J Nutr. 1998;128:1861-1868.
75. Morris D. Cyanogenic glycosides in flaxseed: implications for the health of North Americans. Winnepeg, Manitoba, Canada: Flax Council of Canada; 2000.